EGM
HRTX icon

Engineers Gate Manager’s Heron Therapeutics HRTX Stock Holding History

Engineers Gate Manager’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-27,607
Closed -$42.2K – 2333
2024
Q4 		$42.2K Buy
+27,607
New +$44.7K ﹤0.01% 2110
2024
Q3 		– Sell
-16,192
Closed -$56.7K – 2231
2024
Q2 		$56.7K Sell
16,192
-58,946
-78% -$181K ﹤0.01% 1806
2024
Q1 		$208K Buy
75,138
+6,719
+10% +$16.9K 0.01% 1638
2023
Q4 		$116K Buy
68,419
+46,502
+212% +$51.2K ﹤0.01% 1754
2023
Q3 		$22.6K Buy
21,917
+4,269
+24% +$6.08K ﹤0.01% 1703
2023
Q2 		$20.5K Buy
+17,648
New +$31.5K ﹤0.01% 1667
2022
Q3 		– Sell
-159,476
Closed -$445K – 1816
2022
Q2 		$445K Buy
159,476
+146,638
+1,142% +$589K 0.02% 1176
2022
Q1 		$73K Buy
+12,838
New +$93.9K ﹤0.01% 1739
2021
Q4 		– Sell
-11,006
Closed -$118K – 2128
2021
Q3 		$118K Buy
+11,006
New +$134K 0.01% 1517
2020
Q3 		– Sell
-39,375
Closed -$579K – 1812
2020
Q2 		$579K Sell
39,375
-3,861
-9% -$63.4K 0.03% 880
2020
Q1 		$508K Buy
43,236
+29,628
+218% +$557K 0.04% 751
2019
Q4 		$320K Sell
13,608
-4,319
-24% -$95.6K 0.01% 1230
2019
Q3 		$332K Buy
+17,927
New +$330K 0.02% 964
2019
Q2 		– Sell
-34,300
Closed -$838K – 1244
2019
Q1 		$838K Buy
+34,300
New +$898K 0.05% 489

Other funds holding HRTX

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Engineers Gate Manager's HRTX Position: Q1 2025 in Review

Engineers Gate Manager sold out of Heron Therapeutics (HRTX) in Q1 2025, closing a stake of 27,607 shares — an estimated $42.2K sold.

Engineers Gate Manager first reported a position in HRTX in Q1 2019 and held it in 14 quarters. The position peaked at $838K in Q1 2019. 164 funds tracked by Wall St. Rank hold HRTX as of Q1 2025.

  • Engineers Gate Manager reported no remaining Heron Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Engineers Gate Manager sold 27,607 Heron Therapeutics shares in Q1 2025, an estimated $42.2K.
  • Engineers Gate Manager first reported a position in Heron Therapeutics in Q1 2019 and held it in 14 quarters.
  • Engineers Gate Manager's Heron Therapeutics position peaked at $838K in Q1 2019.
  • 164 funds tracked by Wall St. Rank held Heron Therapeutics as of Q1 2025.

Based on Engineers Gate Manager's 13F filing for Q1 2025, filed 15 May 2025.